Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and ...

The National Kidney Foundation will celebrate the recipients of its top awards — including two NKyians — at its annual Dining ...

For the almost 520,000 Americans who will undergo treatment this year, the process leaves little room for a full life. An innovative new device could change everything.

Around 20 million Americans reportedly trust this medication—here are the recall details, and the unusual error that caused ...

Theories suggest UTI and constipation are related, but one does not necessarily cause the other at this stage in research. Learn about treating both here.

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.

Thiazolidinedione use was associated with lower risk for mortality and cardiorenal events among adults with type 2 diabetes and acute kidney disease.

Diabetes affects an estimated 415 million people worldwide, with type 2 diabetes (T2D) accounting for about 90% of these cases. T2D develops when the pancreas cannot produce enough insulin, the ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.